- Previous Close
2.9000 - Open
2.9300 - Bid 2.8700 x --
- Ask 2.9600 x --
- Day's Range
2.9000 - 2.9800 - 52 Week Range
1.6450 - 3.2000 - Volume
418,953 - Avg. Volume
708,371 - Market Cap (intraday)
683.169M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2600 - Earnings Date Feb 18, 2025 - Feb 24, 2025
- Forward Dividend & Yield 0.06 (1.99%)
- Ex-Dividend Date Aug 30, 2024
- 1y Target Est
3.16
Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.
www.integraldiagnostics.com.au1,977
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: IDX.AX
View MorePerformance Overview: IDX.AX
Trailing total returns as of 11/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IDX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IDX.AX
View MoreValuation Measures
Market Cap
678.49M
Enterprise Value
993.85M
Trailing P/E
--
Forward P/E
22.32
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.44
Price/Book (mrq)
2.25
Enterprise Value/Revenue
2.12
Enterprise Value/EBITDA
147.61
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.92%
Return on Assets (ttm)
3.36%
Return on Equity (ttm)
-17.99%
Revenue (ttm)
469.7M
Net Income Avi to Common (ttm)
-60.7M
Diluted EPS (ttm)
-0.2600
Balance Sheet and Cash Flow
Total Cash (mrq)
42.44M
Total Debt/Equity (mrq)
118.59%
Levered Free Cash Flow (ttm)
37.44M